Check out the new and improved FiercePharmaManufacturing website

Arsalan Arif, Publisher
Follow me on Twitter and LinkedIn

Dear readers: We've completed a major overhaul of FiercePharmaManufacturing's website.

We had one guiding principle with the redesign. It's best captured by Jay Rosen, a prominent press critic and journalism professor at NYU:

"The simplest way to create value in journalism is to save the user time."

Please explore the streamlined new design and let us know if we indeed are saving you time. You, our readers, are some of the busiest executives in the world, so our mission is to give you great content and context in the daily pharma news picture as expeditiously as possible. Drop me a line, tell us how we're doing in that regard. After all, we built it for you.

 

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.